Ron Cohen - Net Worth and Insider Trading
Ron Cohen Net Worth
The estimated net worth of Ron Cohen is at least $101 dollars as of 2024-12-28. Ron Cohen is the President and CEO of Acorda Therapeutics Inc and owns about 7,488 shares of Acorda Therapeutics Inc (ACORQ) stock worth over $101. Details can be seen in Ron Cohen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ron Cohen has not made any transactions after 2023-03-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ron Cohen
Ron Cohen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ron Cohen owns 2 companies in total, including Acorda Therapeutics Inc (ACORQ) , and Dyax Corp (DYAX) .
Click here to see the complete history of Ron Cohen’s form 4 insider trades.
Insider Ownership Summary of Ron Cohen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ACORQ | Acorda Therapeutics Inc | 2023-03-17 | CEO and President |
| DYAX | Dyax Corp | 2016-01-22 | other: Former director |
Ron Cohen Latest Holdings Summary
Ron Cohen currently owns a total of 1 stock. Ron Cohen owns 7,488 shares of Acorda Therapeutics Inc (ACORQ) as of March 17, 2023, with a value of $101.
Latest Holdings of Ron Cohen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACORQ | Acorda Therapeutics Inc | 2023-03-17 | 7,488 | 0.01 | 101 |
Holding Weightings of Ron Cohen
Ron Cohen Form 4 Trading Tracker
According to the SEC Form 4 filings, Ron Cohen has made a total of 2 transactions in Acorda Therapeutics Inc (ACORQ) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Acorda Therapeutics Inc is the acquisition of 1,008 shares on March 17, 2023, which cost Ron Cohen around $12,497.
Insider Trading History of Ron Cohen
- 1
Ron Cohen Trading Performance
GuruFocus tracks the stock performance after each of Ron Cohen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ron Cohen is 16.57%. GuruFocus also compares Ron Cohen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ron Cohen within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Ron Cohen's insider trading performs compared to the benchmark.
Performance of Ron Cohen
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.61 | | | | | |
| Relative Return to S&P 500(%) | -4.14 | | | | | |
Ron Cohen Ownership Network
Ron Cohen Owned Company Details
What does Acorda Therapeutics Inc do?
Who are the key executives at Acorda Therapeutics Inc?
Ron Cohen is the CEO and President of Acorda Therapeutics Inc. Other key executives at Acorda Therapeutics Inc include Chief Financial Officer Michael A Gesser , General Counsel Neil S. Belloff , and Chief Commercial Officer Kerry M Clem .
Acorda Therapeutics Inc (ACORQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Acorda Therapeutics Inc (ACORQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acorda Therapeutics Inc (ACORQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Acorda Therapeutics Inc (ACORQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Acorda Therapeutics Inc Insider Transactions
Ron Cohen Mailing Address
Above is the net worth, insider trading, and ownership report for Ron Cohen. You might contact Ron Cohen via mailing address: C/o Acorda Therapeutics, Inc., 420 Saw Mill River Road, Ardsley Ny 10502.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
